Assessment of efficacy of weekly paclitaxel chemotherapy in ovarian cancers
Phase 2
- Conditions
- Advanced Ovarian Cancer.Malignant neoplasm of ovary
- Registration Number
- IRCT2017050333789N1
- Lead Sponsor
- Taleghani Hospital- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 14
Inclusion Criteria
Age over 18yr; Ovarian cancer confirmed by biopsy and pathology; Advanced disease confirmed by CT scan (Stage III or IV); No previous history of chemotherapy; Good liver and lung functional status; No candidate for primary surgery due to underlying disease; Full access to patients medical documents; Patient satisfaction for study participation
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression-free survival (PFS). Timepoint: At the end of followup study. Method of measurement: Cancer free duration after end of tratment period.
- Secondary Outcome Measures
Name Time Method Anemia. Timepoint: After each 21 day treatment course. Method of measurement: CBC.;Neutropenia. Timepoint: After each 21 day treatment course. Method of measurement: CBC.;Trombocytopenia. Timepoint: After each 21 day treatment course. Method of measurement: CBC.;Neuropathy. Timepoint: After each 21 day treatment course. Method of measurement: Clinical Exam.